CrossBridge Bio’s innovative approach to create stable, multi-loaded antibody–drug conjugates is set to generate a suite of first-in-class and best-in-class cancer therapies. Antibody–drug ...

Teams do not pay a fee for placement on Forbes Top Advisor rankings, which are independently determined by Shook Research. Source: Forbes.com (Awarded Jan 2025) Data Compiled By Shook Research LLC ...

Manish Singh, the chief investment officer at Crossbridge Capital, discusses the market reaction to U.S. President Donald Trump's policies. Judge says dismantling of USAID was unconstitutional See ...